![1]()
News
Obesity boosts risks in COVID-19 from diagnosis to death
September 1, 2020
Excess pounds are linked to excess infection, hospitalization, ICU admission, and mortality.
![1]()
News
HOME-PE trial clarifies which pulmonary embolism patients to treat at home
September 1, 2020
“Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides
![1]()
News
ESC’s revised NSTE-ACS guidelines embrace hsT, personalized anti-ischemia treatments
August 31, 2020
The first guideline update in 5 years for non ST-elevation ACS stresses high sensitivity troponin for diagnosis and tailored antiplatelet treatments.
News
FDA expands remdesivir use for all COVID-19 hospitalized patients
August 31, 2020
An EUA of remdesivir issued in May allowed the drug to be used only for patients with severe COVID-19, specifically, COVID-19 patients with low blood oxygen levels or who need oxygen therapy or mechanical ventilation.
![1]()
News
Gut bacteria linked to cardiovascular, other health conditions
August 31, 2020
“Microbiota and their metabolites ... could serve as potential therapeutic targets for the maintenance of health and prevention and treatment of cardiovascular diseases.”
![1]()
News
NYC public hospitals rose to the demands of the COVID-19 crisis
August 31, 2020
“We hospitalists, and all those recruited to act as hospitalists, essentially took responsibility for the COVID response.”
![1]()
News
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
August 31, 2020
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
News
COVID-19 at home: What does optimal care look like?
August 31, 2020
Most attention has focused on the sickest patients, leaving less severe cases to fall through the cracks.
![1]()
News
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects
August 30, 2020
The 25% cut in primary endpoints among HFrEF patients on empagliflozin matched the benefit seen before from dapagliflozin in DAPA-HF.
![1]()
News
Early rhythm control in AFib gains new life
August 30, 2020
EAST-AFNET 4 trial reanimates rhythm-control strategy as superior for 5-year cardiovascular outcomes.
